Marco Exams interprets genetic, imaging, and pathological exam results to generate diagnoses, prognostic information, and structured therapeutic suggestions. It converts complex technical results into actionable clinical recommendations for the medical team.
Some answers to questions we often receive
Marco Exams processes results from genomic sequencing (NGS), immunohistochemistry, anatomical pathology, diagnostic imaging (CT, PET, MRI), and other specialized oncology exams.
Yes. Marco Exams is prepared to process WGS, WES, and gene panel results, interpreting variants in the context of the available clinical evidence for each tumor type.
Yes. Marco Exams can generate report versions for different audiences: a detailed technical report for the medical team and a patient-friendly summary, both based on the same clinical interpretation.
Marco Exams connects via API to the laboratory or hospital system, automatically processing results and returning the structured clinical report to the existing workflow.
Marco Exams classifies variants of uncertain significance using ACMG/AMP criteria, contextualizes available evidence for each variant, and flags ongoing studies that may lead to reclassification, supporting the clinical team's decision-making.
Yes. Marco Exams connects directly to pathology laboratory systems to process histopathological reports and automatically generate contextualized clinical interpretation.
Hospitals receive results from complex exams —genomic, pathological, imaging— but don't always have the time or expertise to interpret them thoroughly in the context of the most recent evidence.
